Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

TiGenix (NYSE Euronext: TIG) Obtains Manufacturing License For European Production Facility

NYSE Euronext: TIG 's cGMP inspection by the Dutch authorities has obtained the manufacturing authorization for human medicinal products for its European manufacturing plant in Sittard-Geleen in the Netherlands. The Bottom Line: This is a big deal …The state-of-the-art manufacturing site is unique in Europe as it is 100% geared towards the production of innovative cell therapy products. It provides … crucial manufacturing capabilities to support the anticipated growth in demand for ChondroCelect for cartilage repair, and has sufficient capacity for the production of advanced stem cell therapy products.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.